There are ways to prevent, manage, and treat TD, and this podcast will guide you through those steps from FDA-approved medications to off-label therapies.
Chris Aiken, MD
Even as antidepressants improve mood, they can worsen sleep—and poor sleep is both a symptom and a cause of depression.
Behind the controversy is some common ground, buried deep in the DSM. New insights and podcast here.
Experts are divided on the issue, but there’s one thing nearly all agree on.
Once thought untreatable, we now have two FDA-approved medications for TD and a handful of off-label options. More in this research update.
Withdrawal and retreat are the counter-transference pitfalls in TRD. It is often done to the tune of “this is as good as it gets.” Scratch that. A bonus podcast accompanies this piece.
Podcast: Treatment strategies on a long-debated issue, 18 experts reveal what they really do in practice.
Some dyskinesias improve with antipsychotic treatment, and these types are more common than thought. More in this podcast.
Bupropion is one of the better tolerated antidepressants, but concerns about anxiety, insomnia, and seizures have dampened its popularity. In this podcast, we’ll see how well those concerns hold up to the evidence.
Are mood stabilizers causing strokes? Can we treat bipolar II without medication? The past year brought answers to these questions and more.